BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/3/2015 8:26:00 AM | Browse: 1527 | Download: 2462
Publication Name World Journal of Cardiology
Manuscript ID 16696
Country Switzerland
ISSN 1949-8462 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Allergy
Manuscript Type Frontier
Article Title Cost-effectiveness modelling of percutaneous coronary interventions in stable coronary artery disease
Manuscript Source Invited Manuscript
All Author List Ariel Beresniak, Thibaut Caruba, Brigitte Sabatier, Yves Juillière, Olivier Dubourg and Nicolas Danchin
Funding Agency and Grant Number
Funding Agency Grant Number
Sanofi-Aventis
Corresponding Author Ariel Beresniak, MD, MPH, PhD, Data Mining International, Research and Development, Route de l’Aéroport, 29-31, CP221, CH-1215 Geneva, Switzerland. aberesniak@datamining-international.com
Key Words Cost-effectiveness; Percutaneous coronary; Coronary artery disease; Drug eluting stent
Core Tip The objective of this study is to develop a robust cost-effectiveness model comparing drug eluting stents (DES) vs bare metal stent (BMS) in patients suffering of stable coronary artery disease. DES appeared slightly more efficacious over 2 years (60% of success) when compared to BMS (58% of success). Mean cost-effectiveness ratios showed slightly lower costs per success for the BMS strategy (15520€/success), as compared to the DES strategy (15588€/success). The sequential strategy including BMS as the first option appears to be less efficacious but more cost-effective compared to the strategy including DES as first option.
Publish Date 2015-11-03 08:25
Citation Beresniak A, Caruba T, Sabatier B, Juillière Y, Dubourg O, Danchin N. Cost-effectiveness modelling of percutaneous coronary interventions in stable coronary artery disease. World J Cardiol 2015; 7(10): 594-602
URL http://www.wjgnet.com/1949-8462/full/v7/i10/594.htm
DOI http://dx.doi.org/10.4330/wjc.v7.i10.594
Full Article (PDF) WJC-7-594.pdf
Full Article (Word) WJC-7-594.doc